The COST-funded policy network genderSTE has been developing case studies that connect policy and practice and show the importance of gender balance in fields like science, transport and environment, all linked to the United Nations sustainable urban development goals.
High-level representatives of the COST Member States and Cooperating State, as well as from the European Commission reconfirmed their commitment to the programme at the COST Ministerial Conference in Bratislava on 22 September. The conference was held under the auspices of the Slovak EU Presidency.
Physician and New York Times correspondent Sheri Fink will be presenting her views on the ethical dilemmas that disasters raise at the final conference of Disaster Bioethics Action at Dublin City University on 3-4 October.
COST Action TINNET is competing for the Frontiers Spotlight Conference award for outstanding research collaboration with its research on tinnitus.
The Sun’s impact on our planet’s climate has recently been a hotly debated topic in the context of climate change. The controversy around this issue has led scientists across Europe to dig deeper into the claim that solar activity could be a major cause of global warming.
As Europe’s population ages, the number of people requiring rehabilitation following neurological diseases such as stroke is expected to rise. Specialist care from physiotherapists and occupational therapists offers a chance of regaining independence by recovering lost movement.
What exactly happens as we digest food and what are the implications for our health? Answering these questions will help design healthier foods that could curb the rising rates of obesity, diabetes and cardiovascular disease.
Gases once thought of only as environmental pollutants are now known to be produced by the body. A European research network has identified direct links between these gases and heart failure and cancer, and is now focusing on new drugs to treat such diseases.
A network of over 200 scientists, clinicians and industry partners developed a cost-effective diagnostic tool for measuring the tell-tale signs of dementia and Alzheimer’s.
COST is proud of its continuing partnership with the EuroScience Open Forum. This year, we have invited researchers from some of our best science and technology networks to share with you their experience leading and participating in COST Actions.